格隆汇1月6日丨Alterity Therapeutics(ATHE.US)盘前大涨近40%,报1.16美元,此前公司获得治疗神经退行性疾病的药物专利。 网页链接
$Alterity医疗(ATHE)$ EFFECT - Notice of Effectiveness Filed: 2019-05-21 AccNo: 9999999995-19-001165 Size: 1 KB 网页链接
$Alterity医疗(ATHE)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-05-20 AccNo: 0001144204-19-027175 Size: 29 KB 网页链接
$Alterity医疗(ATHE)$ F-3 - Registration statement by foreign private issuers Filed: 2019-05-13 AccNo: 0001144204-19-025615 Size: 511 KB 网页链接
$Alterity医疗(ATHE)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-05-13 AccNo: 0001144204-19-025424 Size: 31 KB 网页链接
$Alterity医疗(ATHE)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-05-08 AccNo: 0001144204-19-024350 Size: 30 KB 网页链接
$Alterity医疗(ATHE)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-05-06 AccNo: 0001144204-19-023725 Size: 1 MB 网页链接
$Alterity医疗(ATHE)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-05-03 AccNo: 0001144204-19-023388 Size: 39 KB 网页链接
$Alterity医疗(ATHE)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2019-04-18 AccNo: 0001144204-19-020287 Size: 409 KB 网页链接
$Alterity医疗(ATHE)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-04-17 AccNo: 0001144204-19-019971 Size: 98 KB 网页链接
$Alterity医疗(ATHE)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-04-11 AccNo: 0001144204-19-019141 Size: 36 KB 网页链接